Evaluation of drug formularies for pediatric intensive care

Pediatric Critical Care Medicine

Volumn 12, Issue 1, 2011, Pages

  Ceelie, Ilse ^a   van der Starre, Cynthia ^a   Tibboel, Dick ^a   Stol, Kim ^b   Koren, Gideon ^c,d   de Wildt, Saskia N ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

drug doses; drug formularies; drug formulary for children; Dutch intensive care unit; labeling status; Lexi Comp; Micomedex; pediatric drug dosing guidelines; pediatric intensive care; PubMed, EMBASE

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BOSENTAN; ILOPROST; KETANSERIN; MIDAZOLAM; PARACETAMOL; PRESCRIPTION DRUG;

ARTICLE; CONTROLLED STUDY; DRUG DOSES; DRUG FORMULARY; DRUG FORMULARY FOR CHILDREN; HUMAN; INTENSIVE CARE; LEXI-COMP; MICROMEDEX; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL;

DRUG PRESCRIPTIONS; FORMULARIES, HOSPITAL; HUMANS; INTENSIVE CARE UNITS, PEDIATRIC; NETHERLANDS; REPRODUCIBILITY OF RESULTS; STATISTICS, NONPARAMETRIC;

EID: 78751644075     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3181d90228     Document Type: Article

References (22)

1. Benjamin DM: Reducing medication errors and increasing patient safety: Case studies in clinical pharmacology. J Clin Pharmacol 2003; 43:768-783
2. 't Jong GW, Eland IA, Sturkenboom MC, et al: Unlicensed and off label prescription of drugs to children: Population based cohort study. BMJ 2002; 324:1313-1314
3. 't Jong GW, Vulto AG, de Hoog M, et al: A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital. Pediatrics 2001; 108:1089-1093
4. Shann F: Drug Doses. 12th Edition. Parkville, Australia, Collective Pty Ltd, 2003
5. Geneesmiddelencommissie: Geneesmiddelenformularium voor kinderen. Wilhelmina Kinderziekenhuis. Edition 2003. Utrecht, Universitair Medisch Centrum, 2003
6. Reed MD, Rodarte A, Blumer JL, et al: The single-dose pharmacokinetics of midazolam and its primary metabolite in pediatric patients after oral and intravenous administration. J Clin Pharmacol 2001; 41:1359-1369
7. de Wildt SN, de Hoog M, Vinks AA, et al: Pharmacodynamics of midazolam in pediatric intensive care patients. Ther Drug Monit 2005; 27:98-102
8. Anderson BJ, van Lingen RA, Hansen TG, et al: Acetaminophen developmental pharmacokinetics in premature neonates and infants: A pooled population analysis. Anesthesiology 2002; 96:1336-1345
9. Anderson BJ, Woollard GA, Holford NH: A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children. Br J Clin Pharmacol 2000; 50:125-134
10. Prins SA, Van Dijk M, Van Leeuwen P, et al: Pharmacokinetics and analgesic effects of intravenous propacetamol vs rectal paracetamol in children after major craniofacial surgery. Paediatr Anaesth 2008; 18:582-592
11. Sanchez Navarro A: New formulations of amoxicillin/clavulanic acid: A pharmacokinetic and pharmacodynamic review. Clin Pharmacokinet 2005; 44:1097-1115
12. Reed MD: Clinical pharmacokinetics of amoxicillin and clavulanate. Pediatr Infect Dis J 1996; 15:949-954
13. Barst RJ, Ivy D, Dingemanse J, et al: Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension. Clin Pharmacol Ther 2003; 73:372-382
14. Ivy DD, Doran AK, Smith KJ, et al: Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension. J Am Coll Cardiol 2008; 51:161-169
15. Rimensberger PC, Spahr-Schopfer I, Berner M, et al: Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: Vasodilator capacity and cellular mechanisms. Circulation 2001; 103:544-548
16. Hanff LM, Visser W, Roofthooft DW, et al: Ketanserin in pre-eclamptic patients: Transplacental transmission and disposition in neonates. BJOG 2004; 111:863-866
17. Playfor S, Jenkins I, Boyles C, et al: Consensus guidelines on sedation and analgesia in critically ill children. Intensive Care Med 2006; 32:1125-1136
18. Twite MD, Rashid A, Zuk J, et al: Sedation, analgesia, and neuromuscular blockade in the pediatric intensive care unit: Survey of fellowship training programs. Pediatr Crit Care Med 2004; 5:521-532
19. Abdel-Rahman SM, Reed MD, Wells TG, et al: Considerations in the rational design and conduct of phase I/II pediatric clinical trials: Avoiding the problems and pitfalls. Clin Pharmacol Ther 2007; 81:483-494
20. Stephenson T: The medicines for children agenda in the UK. Br J Clin Pharmacol 2006; 61:716-9
21. De Vries TP, Henning RH, Hogerzeil HV, et al: Guide to Good Prescribing. Geneva, World Health Organization, 1994
22. Couper MR: The Delphi technique: Characteristics and sequence model. ANS Adv Nurs Sci 1984; 7:72-77